Intron Biotechnology Inc. (048530)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
2,780. 00
+65
+2.3941%
₩
97.15B Market Cap
- P/E Ratio
400% Div Yield
103,343 Volume
- Eps
₩ 2,715
Previous Close Want to track 048530 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Intron Biotechnology Inc. (048530) Statistics
Valuation metrics
Market Cap 97.15B
Enterprise value 60.8B
Trailing P/E (ttm) -9.06
Forward P/E -
PEG ratio 0.13
Price/Sales (ttm) 12.55
Price/Book (mrq) 1.27
Enterprise Value/Revenue 9.45
Enterprise Value/EBITDA -9.63
Overview
Shares outstanding 30.89M
Float 24.53M
Shares short -
% Held by insiders 0.19%
% Held by institutions 0.01%
Average volume (10 days) 87.21K
Average volume (90 days) 173.5K
Price summary
52-Week low 2,250
52-Week high 7,010
Beta 0.15
50-Day moving average 2,504.43
200-Day moving average 3,407.3
Dividends and splits
Forward annual dividend rate 400
Forward annual dividend yield 0.1272%
Trailing annual dividend rate 100
Trailing annual dividend yield 0.0382%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 15 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 2:1
Last split Date 10 Jan 2019
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.47%
Operating margin -1.28%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.13%
Income Statement
Revenue (ttm) 5.74B
Revenue per share (ttm) 206.25
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 3.04B
EBITDA -5.96B
Net income to common (ttm) -8.96B
Diluted EPS (ttm) -304.08
Quarterly earnings growth (yoy) 0.59%
Balance Sheet
Total cash (mrq) 41.78B
Total cash per share (mrq) 968.17
Total debt (mrq) 3.35B
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 9.81%
Book value per share (mrq) 2,064.42
Cash Flow
Cash flow statement -5.21B
Levered free cash flow (LFCF) -5.37B
